Management of inflammatory bowel diseases in Eastern Europe
about
Ulcerative proctitis: a review of pharmacotherapy and management.Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
P2860
Management of inflammatory bowel diseases in Eastern Europe
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Management of inflammatory bowel diseases in Eastern Europe
@ast
Management of inflammatory bowel diseases in Eastern Europe
@en
type
label
Management of inflammatory bowel diseases in Eastern Europe
@ast
Management of inflammatory bowel diseases in Eastern Europe
@en
prefLabel
Management of inflammatory bowel diseases in Eastern Europe
@ast
Management of inflammatory bowel diseases in Eastern Europe
@en
P2860
P356
P1476
Management of inflammatory bowel diseases in Eastern Europe
@en
P2093
P L Lakatos
P2860
P304
P356
10.1136/PGMJ.2005.043901
P407
P577
2006-04-01T00:00:00Z